Literature DB >> 6235996

Characterization of lymphoid cells in the thyroid of patients with Graves' disease.

A Warford, S M McLachlan, A J Malcolm, E T Young, J R Farndon, B Rees Smith.   

Abstract

The distribution and function of lymphoid cells has been investigated in thyroid glands obtained at operation from 16 patients with Graves' disease (GD) using a peroxidase technique to enumerate total T and B lymphocytes as well as helper and suppressor T cell subsets in tissue sections. A spectrum of lymphocytic infiltration was observed and the increase from minimal numbers of immune cells in some GD thyroids to focal thyroiditis in others appeared to be due to a rise in all the lymphoid cell types analysed and was not the result of major change in any one lymphoid compartment. T cells were diffusely distributed whereas B cells tended to occur in aggregates. Small numbers of OKT6+ cells (possibly antigen presenting cells) were observed although these were less numerous than in lymphoid organs such as tonsil. Lymphoid cell suspensions prepared from the thyroid tissue of five of seven GD individuals treated pre-operatively with propranolol synthesized thyroid autoantibodies spontaneously in culture and this synthesis was decreased in the presence of pokeweed mitogen. Since the OKT8+ T cell subset has been shown to suppress immunoglobulin production by lymphocyte cultures containing mitogen, it appears that the suppressor T cells, which are readily demonstrable in GD thyroid sections, are functional. It seems unlikely, therefore, that a defect in this type of suppression is responsible for the initiation or perpetuation of the autoimmune response to thyroid antigens in GD.

Entities:  

Mesh:

Year:  1984        PMID: 6235996      PMCID: PMC1536285     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

Review 1.  Interaction between antigen-presenting cells and primed T lymphocytes: an assessment of Ir gene expression in the antigen-presenting cell.

Authors:  R H Schwartz; A Yano; W E Paul
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

Review 2.  Immunoperoxidase technique in histopathology: applications, methods, and controls.

Authors:  E Heyderman
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

3.  Evaluation of a tanned red cell technique for thyroid microsomal antibodies.

Authors:  T Bird; J Stephenson
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

4.  Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes.

Authors:  S M McLachlan; A McGregor; B R Smith; R Hall
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

5.  Thyroid antibodies are produced by thyroid-derived lymphocytes.

Authors:  A P Weetman; A M McGregor; J H Lazarus; R Hall
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

6.  Characterization of Langerhans cells by the use of monoclonal antibodies.

Authors:  G F Murphy; A K Bhan; S Sato; T J Harrist; M C Mihm
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

7.  Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.

Authors:  G Janossy; G Panayi; O Duke; M Bofill; L W Poulter; G Goldstein
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

8.  Thyroglobulin and microsomal autoantibody production by cultures of Hashimoto peripheral blood lymphocytes.

Authors:  A McGregor; S McLachlan; F Clark; B R Smith; R Hall
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

9.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

10.  Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes.

Authors:  S M McLachlan; A G Bird; A P Weetman; R Smith; R Hall
Journal:  Scand J Immunol       Date:  1981-09       Impact factor: 3.487

View more
  8 in total

1.  Association between the TAP1 gene codon 637 polymorphism and Graves' disease.

Authors:  Rong-Hsing Chen; Wen-Chi Chen; Ching-Chu Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

2.  Association between the TAP2 gene codon 665 polymorphism and Graves' disease.

Authors:  Rong-Hsing Chen; Tze-Yuan Wang; Wen-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

3.  Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S L Middleton; A Dickinson; F Clark; S J Proctor; G Proud; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

4.  HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.

Authors:  I Todd; R Pujol-Borrell; B A Abdul-Karim; L J Hammond; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

5.  Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.

Authors:  C M Dayan; M Londei; A E Corcoran; B Grubeck-Loebenstein; R F James; B Rapoport; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Cells infiltrating the thyroid in juvenile autoimmune thyroiditis.

Authors:  S Kontiainen; I Lautenschlager; M Nyberg; J Mäenpää
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Association between thyroid microsomal antibodies of subclass IgG-1 and hypothyroidism in autoimmune postpartum thyroiditis.

Authors:  R Jansson; P M Thompson; F Clark; S M McLachlan
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

8.  Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.

Authors:  N Ishikawa; K Eguchi; Y Ueki; M Nakashima; H Shimada; K Ito; S Nagataki
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.